Back to search

Peptide record

TPDB09671

Antibacterial Anticancer Antifungal Antiparasitic Antiviral standard
21 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB09671
Antibacterial Anticancer Antifungal Antiparasitic Antiviral
Anti-infective peptides Cancer-related peptides
AntiBP3 dbAMP DRAMP Peptipedia Antifungipept CAFPdb
standard
No
A 21-aa standard natural multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
GILGNIVGMGKQVVCGLSGLC
Physicochemical Analysis
C86H152N24O25S3
ARDEHFPTWY
G
2018.48
8.29
1
0
9
+1
-0.62
1.229
134.29
Mammalian: 30 hour Yeast: >20 hour E.coli: >10 hour
125
6.19
5
Residue Composition
number
0
A
0
R
1
N
0
D
2
C
0
E
1
Q
6
G
0
H
2
I
3
L
1
K
1
M
0
F
0
P
1
S
0
T
0
W
0
Y
3
V
Amino Acid Distribution
A: 0 R: 0 N: 1 D: 0 C: 2 E: 0 Q: 1 G: 6 H: 0 I: 2 L: 3 K: 1 M: 1 F: 0 P: 0 S: 1 T: 0 W: 0 Y: 0 V: 3
Chemical Descriptors
21
C86H152N24O25S3
2018.48
8.29
+1
-0.62
1.229
Evidence Records 12 records
Evidence 1 Activity

Activity

MIC
Antibacterial
5.1 µg/mL

Target

Escherichia coli

Source & Reference

dbAMP DRAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class. DRAMP antibacterial activity supported by MIC records against bacterial target organisms.
Active against Gram- bacteria E. coli (MIC 5.1 ug/ml), B. pyocyaneus (now called P. aeruginosa) (MIC 10.2 ug/ml), Gram+ bacteria S. aureus (MIC
Evidence 2 Activity

Activity

MIC
Antibacterial
5.1 µg/mL

Target

Staphylococcus aureus

Source & Reference

dbAMP DRAMP

Other

MIC 5.1 ug/ml), B. pyocyaneus (now called P. aeruginosa) (MIC 10.2 ug/ml), Gram+ bacteria S. aureus (MIC 5.1 ug/ml), and yeast C. albicans (MIC 5.1 ug/ml). Updated 7/2021
Evidence 3 Activity

Activity

MIC
Antibacterial
5.1 µg/mL

Target

Candida albicans

Source & Reference

dbAMP DRAMP

Other

lled P. aeruginosa) (MIC 10.2 ug/ml), Gram+ bacteria S. aureus (MIC 5.1 ug/ml), and yeast C. albicans (MIC 5.1 ug/ml). Updated 7/2021
Evidence 4 Activity

Activity

MIC
Antifungal
5.1 µg/mL

Target

Escherichia coli

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class. DRAMP antifungal activity supported by activity records against fungal target organisms.
Active against Gram- bacteria E. coli (MIC 5.1 ug/ml), B. pyocyaneus (now called P. aeruginosa) (MIC 10.2 ug/ml), Gram+ bacteria S. aureus (MIC
Evidence 5 Activity

Activity

MIC
Antifungal
5.1 µg/mL

Target

Staphylococcus aureus

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

MIC 5.1 ug/ml), B. pyocyaneus (now called P. aeruginosa) (MIC 10.2 ug/ml), Gram+ bacteria S. aureus (MIC 5.1 ug/ml), and yeast C. albicans (MIC 5.1 ug/ml). Updated 7/2021
Evidence 6 Activity

Activity

MIC
Antifungal
5.1 µg/mL

Target

Candida albicans

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

lled P. aeruginosa) (MIC 10.2 ug/ml), Gram+ bacteria S. aureus (MIC 5.1 ug/ml), and yeast C. albicans (MIC 5.1 ug/ml). Updated 7/2021
Evidence 7 Activity

Activity

MIC
Antiparasitic
5.1 µg/mL

Target

Escherichia coli

Source & Reference

DRAMP

Other

Source Activity Label Source Definition
Antiparasitic
DRAMP antiparasitic activity supported by activity records against parasitic targets.
Active against Gram- bacteria E. coli (MIC 5.1 ug/ml), B. pyocyaneus (now called P. aeruginosa) (MIC 10.2 ug/ml), Gram+ bacteria S. aureus (MIC
Evidence 8 Activity

Activity

MIC
Antiparasitic
5.1 µg/mL

Target

Staphylococcus aureus

Source & Reference

DRAMP

Other

MIC 5.1 ug/ml), B. pyocyaneus (now called P. aeruginosa) (MIC 10.2 ug/ml), Gram+ bacteria S. aureus (MIC 5.1 ug/ml), and yeast C. albicans (MIC 5.1 ug/ml). Updated 7/2021
Evidence 9 Activity

Activity

MIC
Antiparasitic
5.1 µg/mL

Target

Candida albicans

Source & Reference

DRAMP

Other

lled P. aeruginosa) (MIC 10.2 ug/ml), Gram+ bacteria S. aureus (MIC 5.1 ug/ml), and yeast C. albicans (MIC 5.1 ug/ml). Updated 7/2021
Evidence 10 Activity

Activity

MIC
Antiviral
5.1 µg/mL

Target

Escherichia coli

Source & Reference

DRAMP

Other

Source Activity Label Source Definition
Antiviral
DRAMP antiviral activity supported by activity records against viral targets.
Active against Gram- bacteria E. coli (MIC 5.1 ug/ml), B. pyocyaneus (now called P. aeruginosa) (MIC 10.2 ug/ml), Gram+ bacteria S. aureus (MIC
Evidence 11 Activity

Activity

MIC
Antiviral
5.1 µg/mL

Target

Staphylococcus aureus

Source & Reference

DRAMP

Other

MIC 5.1 ug/ml), B. pyocyaneus (now called P. aeruginosa) (MIC 10.2 ug/ml), Gram+ bacteria S. aureus (MIC 5.1 ug/ml), and yeast C. albicans (MIC 5.1 ug/ml). Updated 7/2021
Evidence 12 Activity

Activity

MIC
Antiviral
5.1 µg/mL

Target

Candida albicans

Source & Reference

DRAMP

Other

lled P. aeruginosa) (MIC 10.2 ug/ml), Gram+ bacteria S. aureus (MIC 5.1 ug/ml), and yeast C. albicans (MIC 5.1 ug/ml). Updated 7/2021